Accession Number:

AD1064689

Title:

Cannabidivarin (CBDV) Versus Placebo in Children with Autism Spectrum Disorder (ASD)

Descriptive Note:

Technical Report,01 Aug 2017,31 Jul 2018

Corporate Author:

Albert Eintsein College of Medicine, Inc. Bronx United States

Personal Author(s):

Report Date:

2018-08-01

Pagination or Media Count:

42.0

Abstract:

The CDC currently estimates 1 in 59 children have Autism Spectrum Disorder ASD. Children with ASD have problems with social communication, irritability, repetitive behaviors, impulsivity, temper tantrums, and a high caregiver burden. The only medications approved by the FDA for symptoms of ASD are aripiprazole and risperidone. Both of these are used to reduce irritability but have short-term and long-term side effects.

Subject Categories:

  • Medicine and Medical Research
  • Psychology

Distribution Statement:

APPROVED FOR PUBLIC RELEASE